PR Newswire

NANJING, China, Sept. 1, 2026 /PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group (2096.HK) today announced that it has entered into an exclusive global licensing agreement with Roche for the development and commercialization of SIM0660, a tri-specific antibody targeting CD

SHANGHAI, Sept. 1, 2026 /PRNewswire/ -- Mech-Mind Robotics, a portfolio company of Qiming Venture Partners and a global-leading robobrain company, successfully listed on the Hong Kong Stock Exchange on September 1, 2026 Beijing time and became the first listed embodied intelligence "Eye-Brain-Hand"

The Australian AI predictions platform that called four out of five underdogs in the NBA Finals has landed on American soil - and it's locked in for the NFL. NEW YORK, Sept. 1, 2026 /PRNewswire/ -- XO Sports has launched into the US, bringing fans NBA, MLB, WNBA, NFL and EPL sporting predictions, ba

The deadline is September 10, 2026. NEW YORK, Sept. 1, 2026 /PRNewswire/ -- The following statement is being issued by Kroll Restructuring Administration and Raymond Chabot Inc. regarding the Asbestos Corporation Limited insolvency proceedings. With less than one month remaining before the September

Joint test on IonQ Forte hardware lands within 4% of benchmark, clearing the chemical-accuracy bar for enzyme active-site modeling via Amazon Braket PALO ALTO, Calif., Sept. 1, 2026 /PRNewswire/ -- QC Ware today announced a technology demonstration of a hybrid quantum-classical chemistry workflow us

New generation of routers delivers expanded routing, automation, security and synchronization capabilities PLANO, Texas, Sept. 1, 2026 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global leader in real-time communications technology, IP routing, and optical networking solutions, toda

Summit to Bring Together More Than 150 CIOs, CTOs, CISOs and Digital Innovation Leaders to Explore Trust, Resilience and the Next Era of Growth KUALA LUMPUR, Malaysia, Sept. 1, 2026 /PRNewswire/ -- The 39th Edition BFSI IT Summit Malaysia 2026 will take place on 9 September 2026 at the InterContinen

Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was Well Tolerated as Monotherapy and in Combination with Checkpoint Inhibition Kazia is Preparing to Advance Paxalis

Preclinical Data Show Paxalisib Combined With Standard-of-Care Therapy Is Well Tolerated and Produces Statistically Significant Antitumor Activity Three-Arm Expansion of the Ongoing TNBC Trial Will Evaluate Paxalisib Plus Fulvestrant, With Palbociclib, Versus Standard-of-Care First Patient Expected

Summit to Bring Together More Than 150 CISOs, CIOs, Government Officials and Cybersecurity Leaders to Explore Identity, Intelligence and Resilience KUALA LUMPUR, Malaysia, Sept. 1, 2026 /PRNewswire/ -- The 34th Edition Cyber Security Summit Malaysia 2026 will take place on 10 September 2026 at the I